tobramycin has been researched along with Abdominal Abscess in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wilson, SE | 1 |
| Azimi, PH; Collins, MD; Dajani, AS; Kaplan, SL; Kim, KS; King, DR; Kolokathis, A; Swanson, R | 1 |
2 trial(s) available for tobramycin and Abdominal Abscess
| Article | Year |
|---|---|
Results of a randomized, multicenter trial of meropenem versus clindamycin/tobramycin for the treatment of intra-abdominal infections.
Topics: Abdominal Abscess; Adolescent; Adult; Aged; Anti-Bacterial Agents; Appendicitis; Bacteria, Anaerobic; Clindamycin; Double-Blind Method; Drug Therapy, Combination; Female; Follow-Up Studies; Gram-Negative Aerobic Bacteria; Gram-Positive Bacteria; Humans; Male; Meropenem; Middle Aged; Thienamycins; Tobramycin; Treatment Outcome | 1997 |
Comparison of ampicillin/sulbactam plus aminoglycoside vs. ampicillin plus clindamycin plus aminoglycoside in the treatment of intraabdominal infections in children. The Multicenter Group.
Topics: Abdominal Abscess; Aminoglycosides; Ampicillin; Bacterial Infections; Child; Child, Preschool; Clindamycin; Drug Therapy, Combination; Female; Gentamicins; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Infant; Male; Prospective Studies; Species Specificity; Sulbactam; Tobramycin; Treatment Outcome | 1998 |